Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03611348

Microneedling and Latanoprost in Acrofacial Vitiligo

Effectiveness of Microneedling and Topical Latanoprost in Treatment of Acrofacial Vitiligo

Sponsor: Sohag University

Conditions Vitiligo

Updated 5 times since 2018 Last updated: Aug 26, 2018 Started: Sep 1, 2018 Primary completion: Sep 1, 2019 Completion: Dec 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03611348, this PHASE2/PHASE3 trial focuses on Vitiligo and remains ongoing. Sponsored by Sohag University, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Sep 2020 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

Status: Not Yet Recruiting → Unknown Status
Sep 2018 — Sep 2020 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sohag University

Data source: Sohag University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.